arrobajuarez.com

Pharmacology Made Easy 5.0 The Cardiovascular System Test

In the context of "Pharmacology Made Easy 5.0," a test on the cardiovascular system would likely focus on the following key ...
Healio

Angiotensin-converting enzyme inhibitors, receptor blockers may benefit patients with CKD

Please provide your email address to receive an email when new articles are posted on . Patients with advanced chronic kidney disease may benefit from use of angiotensin-converting enzyme inhibitors ...
Medscape

Angiotensin II Receptor Blockers in the Treatment of Heart Failure

Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...
ascopubs.org

Impact of angiotensin-converting enzyme inhibitors (ACEis) or angiotensin II receptor blockers (ARBs) on mortality and kidney function in cancer patients receiving cisplatin.

Receiving a cancer diagnosis during hospitalization and associations with care outcomes.
Medscape

Clinical Decision Support Tool May Improve ACEI and ARB Use in CKD

ACEI and ARB use in CKD has been available for over three decades, but it is still underutilized. Now, a new clinical decision support tool may change that.
ascopubs.org

Effects of angiotensin-converting enzyme (ACE) inhibitors on the outcomes of patients receiving primary radiotherapy for prostate cancer (PC).

The free hormone hypothesis: Correlation of decreases in PSA with free testosterone rather than total testosterone in men with advanced prostate cancer treated with GTx-758. Use of supportive measures ...